Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1993 1
1997 2
2008 1
2010 1
2012 1
2014 1
2015 1
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
[Antitumour effects of bisphosphonates in breast cancer].
van de Ven S, Kroep JR, Hamdy NA, Sleeboom HP, Nortier HW. van de Ven S, et al. Among authors: nortier hw. Ned Tijdschr Geneeskd. 2010;154:A1951. Ned Tijdschr Geneeskd. 2010. PMID: 21083955 Review. Dutch.
Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.
Kroep JR, van Werkhoven E, Polee M, van Groeningen CJ, Beeker A, Erdkamp F, Weijl N, van Bochove A, Erjavec Z, Kapiteijn E, Stiggelbout AM, Nortier HW, Gelderblom H. Kroep JR, et al. Among authors: nortier hw. J Geriatr Oncol. 2015 Jul;6(4):307-15. doi: 10.1016/j.jgo.2015.05.004. Epub 2015 Jul 17. J Geriatr Oncol. 2015. PMID: 26073532 Free article. Clinical Trial.
Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer.
Lalisang RI, Wils JA, Nortier HW, Burghouts JT, Hupperets PS, Erdkamp FL, Schouten HC, Blijham GH. Lalisang RI, et al. Among authors: nortier hw. J Clin Oncol. 1997 Apr;15(4):1367-76. doi: 10.1200/JCO.1997.15.4.1367. J Clin Oncol. 1997. PMID: 9193328 Clinical Trial.